Delayed hypersensitivity with ferric carboxymaltose

Surabhi Sridhara, V. Rajesh, Ravindra Prabhu, Karan Saraf

Research output: Contribution to journalArticle

Abstract

Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.

Original languageEnglish
Pages (from-to)FD01-FD02
JournalJournal of Clinical and Diagnostic Research
Volume11
Issue number11
DOIs
Publication statusPublished - 01-11-2017

Fingerprint

Delayed Hypersensitivity
Chronic Renal Insufficiency
Anemia
Hypersensitivity
Thrombocytopenia
ferric carboxymaltose

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{9e65a7c663d54a6c9f6956fc4907bca9,
title = "Delayed hypersensitivity with ferric carboxymaltose",
abstract = "Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.",
author = "Surabhi Sridhara and V. Rajesh and Ravindra Prabhu and Karan Saraf",
year = "2017",
month = "11",
day = "1",
doi = "10.7860/JCDR/2017/25908.10827",
language = "English",
volume = "11",
pages = "FD01--FD02",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "11",

}

Delayed hypersensitivity with ferric carboxymaltose. / Sridhara, Surabhi; Rajesh, V.; Prabhu, Ravindra; Saraf, Karan.

In: Journal of Clinical and Diagnostic Research, Vol. 11, No. 11, 01.11.2017, p. FD01-FD02.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delayed hypersensitivity with ferric carboxymaltose

AU - Sridhara, Surabhi

AU - Rajesh, V.

AU - Prabhu, Ravindra

AU - Saraf, Karan

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.

AB - Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.

UR - http://www.scopus.com/inward/record.url?scp=85034631111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034631111&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2017/25908.10827

DO - 10.7860/JCDR/2017/25908.10827

M3 - Article

VL - 11

SP - FD01-FD02

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 11

ER -